ClinicalTrials.gg
Drug

Plozasiran clinical trials

studies test it
11
open now
1
in phase 3
7
first study started
2019

How each study uses plozasiran is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the plozasiran studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
18 Nov 2025 · REDEMPLO · NDA 219947 (FDA, Drugs@FDA)
European Union
19 Jun 2026 · Redemplo · EMEA/H/C/006579 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

ARO-APOC3
11
Plozasiran Injection
4
Plozasiran
4

Development codes

SAR449124
1
VSA001
1

Studies by the year they started

11 studies that test it; most in 2021 (3)

Studies that test plozasiran, by start year
YearStudies
20191
20213
20221
20231
20243
20252

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
3
Phase 3
7

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 11 · Other 0

Arrowhead Pharmaceuticals (10) · Visirna Therapeutics HK Limited (1)

Studies

Open first, then newest update. How each study uses plozasiran is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 11

Codes

What other systems call plozasiran · ClinicalTrials.gg INT002109

  • MeSH (NLM) C000731231plozasiranConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) XG9ARL6P25PLOZASIRANConfirmed FDA, NLM, Wikidata
  • Wikidata Q136334524PlozasiranConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C203193PlozasiranOne source FDA
  • DrugBank DB18997One source Wikidata

Also registered as plozasiran sodium (UNII U93HYZ4QU8).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.